Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Sarcoma 10 Sarcoma, Ewing 4 Liposarcoma 4 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Osteosarcoma 3 Neuroblastoma 3 Medulloblastoma 3 Glioma 3 Wilms Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Chordoma 2 Breast Neoplasms 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Liposarcoma, Myxoid 1 Histiocytic Sarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1

Interventions

Temozolomide 131 Radiotherapy 87 Bevacizumab 43 Radiation 31 Carmustine 29 Magnetic Resonance Spectroscopy 22 Irinotecan 22 Erlotinib Hydrochloride 22 Chemotherapy, Adjuvant 20 Surgical Procedures, Operative 15 O(6)-benzylguanine 15 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Radiotherapy, Conformal 13 sargramostim 12 Sirolimus 9 Imatinib Mesylate 9 Filgrastim 9 Drug Therapy 9 temsirolimus 8 Thalidomide 8 Sorafenib 8 Radiosurgery 8 pembrolizumab 7 motexafin gadolinium 7 aldesleukin 7 Vorinostat 7 Procarbazine 7 Gene Expression Profiling 7 Gefitinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gliosarcoma × palbociclib × Sarcoma × Clear all

NCT01227434 2015-07-17

PD0332991

University of California, San Francisco

Phase 2 Terminated

23 enrolled 8 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡